Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.850
-0.020 (-0.70%)
Feb 21, 2025, 4:00 PM EST - Market closed

Mereo BioPharma Group Market Cap

Mereo BioPharma Group has a market cap or net worth of $441.46 million as of February 21, 2025. Its market cap has decreased by -21.36% in one year.

Market Cap
441.46M
Enterprise Value
367.62M
1-Year Change
-21.36%
Ranking
Category
Stock Price
$2.85

Market Cap Chart

Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $441.46M, an increase of 253.64%. That is a compound annual growth rate of 24.17%.

History

DateMarket Cap% Change
Feb 21, 2025441.46M-18.57%
Dec 31, 2024542.14M67.64%
Dec 29, 2023323.39M269.38%
Dec 30, 202287.55M-49.64%
Dec 31, 2021173.85M-28.05%
Dec 31, 2020241.63M276.02%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.71B
UnitedHealth Group 429.24B
Novo Nordisk 391.83B
Johnson & Johnson 390.76B
AbbVie 356.74B
Abbott Laboratories 234.01B
AstraZeneca 229.50B
Merck & Co. 226.40B
Market Cap Rankings